DEEP Substrate Mapping Versus Activation Mapping for VT — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

DEEP Substrate Mapping Versus Activation Mapping for VT — Stella

Home/Ventricular Tachycardia/

View on ClinicalTrials.gov

Recruiting

Back to Ventricular Tachycardia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Italy

San Raffaele Hospital, Milan, Lombardy

Key details

Sponsor

IRCCS Ospedale San Raffaele

Enrollment target

~222 participants

Started

June 2024

Primary completion

June 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.